Growing Focus on R&D to Develop Next-generation Embolic Protection Devices Coupled with Surge in the Number of Percutaneous Procedures Likely to Enable Growth in the North America Embolic Protection Devices Market

Published: May 2021

The North America embolic protection devices market is estimated to display a significant CAGR of 8.3% during the forecast period (2021-2027). The growing focus of vendors in R&D to develop next-generation embolic protection devices is likely to have a significant impact on market growth. Moreover, several key players such as Boston Scientific, Medtronic, Abbott are also present in the region that focuses on offering a diverse range of embolic protection devices. Continued product innovations and modifications to existing devices by leveraging the latest technological platforms are expected to bring more effective and safer embolic protection devices. Both major and emerging players' continuous involvement in R&D activities will lead to the development of several innovative products over the next few years, thereby positively influencing the embolic protection devices market in the region.

Browse the full report description of "North America Embolic Protection Devices Market Size, Share & Trends Analysis Report by Product (Filter Devices and Occlusion Devices), by Application (Cardiovascular & Peripheral and Neurovascular), and by End-user (Ambulatory Surgery Centers, Freestanding CATH Labs, Hospitals, and Specialty Cardiac Centers) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/north-america-embolic-protection-devices-market

Furthermore, the region has witnessed a surge in the number of various percutaneous procedures for treating CVDs and transcatheter procedures for treating AS. For instance, around 60% increase in atherectomy cases were reported among Medicare beneficiaries between 2011 and 2014 in the region. Such growth will lead to an increase in complications associated with the procedures; therefore, it will increase the uptake of embolic protection devices in North America. Moreover, the demand for embolic protection devices in the region is driven by high awareness, the presence of a large pool of the patient population, a high penetration rate, technological advancements, better product availability, and extensive reach of innovative products. 

Market Coverage

  • Market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segments Covered- by Product, Application, and End-user
  • Countries Covered- US and Canada
  • Competitive Landscape- Abbott; Boston Scientific Corp.; Cardinal Health, Inc.; and Medtronic plc

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

North America Embolic Protection Devices Market Report Segment

By Product 

  • Filter Devices
  • Occlusion Devices

By Application

  • Cardiovascular & Peripheral
  • Neurovascular

By End-user

  • Ambulatory Surgery Centers
  • Freestanding CATH Labs
  • Hospitals
  • Specialty Cardiac Centers

North America Embolic Protection Devices Market Report Segment

  • US
  • Canada 

To learn more about this report request a sample copy @  https://www.omrglobal.com/request-sample/north-america-embolic-protection-devices-market